An increase of miR-155, which is seen in liver tissues of patients with HCV-derived HCC and in HCC cell lines, can cause IGFBP3 expression to decrease, while transfection of miR-155 inhibitor into HCC cells can rescue IGFBP3 expression [105]. The gene discussed is IGFBP3; the disease is hepatocellular carcinoma.